SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
Current Report Pursuant
to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported) February 13, 2003
BOSTON BIOMEDICA, INC.
----------------------------------------------------
(Exact Name Of Registrant As Specified In Its Charter)
MASSACHUSETTS
--------------------------------------------
(State or Other Jurisdiction of Incorporation)
0-21615 04-2652826
---------------------- ---------------------------------
(Commission File Number) (I.R.S.Employer Identification No.)
375 West Street, West Bridgewater, MA 02379
-------------------------------------- --------
(Address of Principal Executive Offices) (Zip Code)
(508) 580-1900
--------------------------------------------------
(Registrant's Telephone Number, Including Area Code)
N/A
-----------------------------------------------------------
(Former Name or Former Address, if Changed Since Last Report)
ITEM 5. OTHER EVENTS
------
On February 14, 2003, Boston Biomedica, Inc. announced that the Company's Board
of Directors had terminated Richard T. Schumacher as Chairman and Chief
Executive Officer. A copy of the press release issued on February 14, 2003
regarding the termination of Mr. Schumacher is filed as Exhibit 99.1.
ITEM 7. EXHIBITS
------
Exhibit Number Description
-------------- -----------
99.1 Press Release dated February 14, 2003
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this Report to be signed on its behalf by the
undersigned hereunto duly authorized.
Dated: February 24, 2003 BOSTON BIOMEDICA, INC.
By: /s/ Kevin W. Quinlan
--------------------------------------
Kevin W. Quinlan,
President and Chief Operating Officer
and Treasurer
INDEX TO EXHIBITS
Exhibit
Number Description
----------- ------------------------------------------------------
99.1 Press Release dated February 14, 2003